Viewing Study NCT07271251


Ignite Creation Date: 2025-12-24 @ 11:57 PM
Ignite Modification Date: 2025-12-25 @ 9:54 PM
Study NCT ID: NCT07271251
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-09
First Post: 2025-11-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module